Pharmaids Pharmaceuticals Limited (PHARMAID.BO)
INR 64.39
(-2.42%)
INR 64.39
(-2.42%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 151.12 Million INR | 0.0% |
| 2022 | - INR | -100.0% |
| 2021 | 39.39 Million INR | -53.93% |
| 2020 | 85.51 Million INR | 0.0% |
| 2019 | - INR | -100.0% |
| 2018 | 5.61 Million INR | 24.93% |
| 2017 | 4.49 Million INR | -62.65% |
| 2016 | 12.02 Million INR | -28.61% |
| 2015 | 16.84 Million INR | -2.65% |
| 2014 | 17.3 Million INR | 23.14% |
| 2013 | 14.05 Million INR | 10.25% |
| 2012 | 12.74 Million INR | 3.19% |
| 2011 | 12.35 Million INR | 57.57% |
| 2010 | 7.83 Million INR | 53.68% |
| 2009 | 5.1 Million INR | 21.08% |
| 2008 | 4.21 Million INR | -9.61% |
| 2007 | 4.66 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 46.74 Million INR | -19.49% |
| 2023 Q4 | 58.05 Million INR | 27812.98% |
| 2023 Q3 | 208 Thousand INR | 0.0% |
| 2023 Q2 | - INR | 0.0% |
| 2023 Q1 | - INR | 0.0% |
| 2023 FY | 151.12 Million INR | 0.0% |
| 2022 Q2 | - INR | 0.0% |
| 2022 FY | - INR | -100.0% |
| 2022 Q3 | - INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | - INR | 0.0% |
| 2021 Q4 | 3.02 Million INR | -58.2% |
| 2021 Q3 | 7.23 Million INR | 26.73% |
| 2021 FY | 39.39 Million INR | -53.93% |
| 2021 Q1 | 23.41 Million INR | 24.21% |
| 2021 Q2 | 5.71 Million INR | -75.61% |
| 2020 Q3 | 34.1 Million INR | 4.74% |
| 2020 Q1 | - INR | 0.0% |
| 2020 Q2 | 32.55 Million INR | 0.0% |
| 2020 FY | 85.51 Million INR | 0.0% |
| 2020 Q4 | 18.85 Million INR | -44.72% |
| 2019 FY | - INR | -100.0% |
| 2019 Q1 | 120 Thousand INR | 0.0% |
| 2019 Q2 | -120 Thousand INR | -200.0% |
| 2019 Q3 | - INR | 100.0% |
| 2019 Q4 | - INR | 0.0% |
| 2018 FY | 5.61 Million INR | 24.93% |
| 2018 Q4 | - INR | -100.0% |
| 2018 Q3 | 5.09 Million INR | 0.0% |
| 2018 Q2 | - INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q4 | 311 Thousand INR | -82.04% |
| 2017 FY | 4.49 Million INR | -62.65% |
| 2017 Q3 | 1.73 Million INR | 253.47% |
| 2017 Q2 | 490 Thousand INR | -74.97% |
| 2017 Q1 | 1.95 Million INR | -24.08% |
| 2016 Q2 | 3.11 Million INR | -8.83% |
| 2016 Q1 | 3.42 Million INR | 28.81% |
| 2016 Q4 | 2.57 Million INR | -11.31% |
| 2016 Q3 | 2.9 Million INR | -6.74% |
| 2016 FY | 12.02 Million INR | -28.61% |
| 2015 Q1 | 5.74 Million INR | 79.99% |
| 2015 FY | 16.84 Million INR | -2.65% |
| 2015 Q2 | 3.16 Million INR | -44.93% |
| 2015 Q3 | 5.27 Million INR | 66.61% |
| 2015 Q4 | 2.65 Million INR | -49.67% |
| 2014 Q1 | 4.51 Million INR | 11.68% |
| 2014 Q4 | 3.19 Million INR | -36.89% |
| 2014 Q2 | 4.52 Million INR | 0.27% |
| 2014 FY | 17.3 Million INR | 23.14% |
| 2014 Q3 | 5.06 Million INR | 11.75% |
| 2013 FY | 14.05 Million INR | 10.25% |
| 2013 Q4 | 4.04 Million INR | 42.51% |
| 2013 Q3 | 2.83 Million INR | 0.0% |
| 2013 Q2 | 2.83 Million INR | 4.61% |
| 2013 Q1 | 2.71 Million INR | -56.6% |
| 2012 Q3 | 3.36 Million INR | 7.68% |
| 2012 Q1 | 3.81 Million INR | 44.05% |
| 2012 Q4 | 6.25 Million INR | 85.67% |
| 2012 FY | 12.74 Million INR | 3.19% |
| 2012 Q2 | 3.12 Million INR | -18.06% |
| 2011 Q3 | 2.99 Million INR | 0.0% |
| 2011 FY | 12.35 Million INR | 57.57% |
| 2011 Q4 | 2.64 Million INR | -11.61% |
| 2010 Q4 | 1.65 Million INR | 0.0% |
| 2010 FY | 7.83 Million INR | 53.68% |
| 2009 Q4 | 626 Thousand INR | 0.0% |
| 2009 FY | 5.1 Million INR | 21.08% |
| 2008 FY | 4.21 Million INR | -9.61% |
| 2008 Q4 | 1.08 Million INR | 0.0% |
| 2007 FY | 4.66 Million INR | 0.0% |
| 2007 Q4 | 1.05 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| ANG Lifesciences India Limited | 1.46 Billion INR | 89.657% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 92.522% |
| Bacil Pharma Limited | - INR | -Infinity% |
| BDH Industries Limited | 858.31 Million INR | 82.393% |
| Beryl Drugs Limited | 271.24 Million INR | 44.287% |
| Cian Healthcare Limited | 616.95 Million INR | 75.505% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -722.114% |
| Concord Drugs Limited | 449.24 Million INR | 66.361% |
| Deccan Health Care Limited | 597.28 Million INR | 74.699% |
| DECIPHER LABS LIMITED | 362.75 Million INR | 58.341% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | 68.5% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 91.101% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -1340.684% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 89.355% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | 0.497% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 95.08% |
| Panchsheel Organics Limited | 1.05 Billion INR | 85.637% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 85.591% |
| Parnax Lab Limited | 1.88 Billion INR | 91.992% |
| Makers Laboratories Limited | 1.03 Billion INR | 85.436% |
| Medi-Caps Limited | 265.63 Million INR | 43.11% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.731% |
| Phaarmasia Limited | 305.93 Million INR | 50.603% |
| Parmax Pharma Limited | 154.24 Million INR | 2.024% |
| Patidar Buildcon Limited | 2.3 Million INR | -6447.704% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 71.852% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -13417.084% |
| Trident Lifeline Limited | 446.28 Million INR | 66.138% |
| Tyche Industries Limited | 696.83 Million INR | 78.313% |
| Vivanza Biosciences Limited | 278.89 Million INR | 45.814% |
| PRAVEG LIMITED | 915.96 Million INR | 83.501% |
| Smruthi Organics Limited | 1.27 Billion INR | 88.161% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | 44.638% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 96.74% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 98.886% |
| Transchem Limited | 4.09 Million INR | -3585.879% |
| Trinity League India Limited | 2.95 Million INR | -5022.746% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 87.95% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -46.893% |
| Sunil Healthcare Limited | 901.91 Million INR | 83.245% |
| Syschem (India) Limited | 2.33 Billion INR | 93.529% |
| Zenith Healthcare Limited | 144.71 Million INR | -4.425% |
| Zenlabs Ethica Limited | 585.63 Million INR | 74.195% |
| Mercury Laboratories Limited | 755.59 Million INR | 80.0% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | 62.241% |
| Vasundhara Rasayans Limited | 370.18 Million INR | 59.177% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | 66.123% |
| Roopa Industries Limited | 715.53 Million INR | 78.88% |
| PANJON LTD. | 125.52 Million INR | -20.395% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 97.664% |
| Crestchem Limited | 212.56 Million INR | 28.905% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -2621.92% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 77.539% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 95.659% |
| Trimurthi Limited | 42.23 Million INR | -257.784% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 79.735% |
| Norris Medicines Limited | 56.35 Million INR | -168.154% |
| Veerhealth Care Limited | 142.13 Million INR | -6.323% |
| Lactose (India) Limited | 1.13 Billion INR | 86.731% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | 61.879% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 91.331% |
| Gennex Laboratories Limited | 867.14 Million INR | 82.573% |
| Denis Chem Lab Limited | 1.67 Billion INR | 90.995% |
| Colinz Laboratories Limited | 70.29 Million INR | -114.978% |
| Godavari Drugs Limited | 1.56 Billion INR | 90.357% |
| Zenotech Laboratories Limited | 368.08 Million INR | 58.944% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 87.996% |
| Bharat Parenterals Limited | 2.59 Billion INR | 94.174% |
| Coral Laboratories Limited | 836.6 Million INR | 81.936% |
| Evoq Remedies Limited | 63.09 Million INR | -139.532% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 85.233% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 90.277% |
| Auro Laboratories Limited | 526.99 Million INR | 71.324% |